Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Molecular Biology|August 4, 2004
In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulationLaurent Magnenat, Pilar Blancafort, Carlos F BarbasNature Biotechnology|February 20, 2003
Scanning the human genome with combinatorial transcription factor librariesPilar Blancafort, Laurent Magnenat, Carlos F BarbasMolecular and Cellular Biology|October 4, 2005
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biologyCaren V Lund, Mikhail Popkov, Laurent Magnenat, et al.The Journal of Biological Chemistry|November 13, 2004
Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell diseaseTorbjörn Gräslund, Xuelin Li, Laurent Magnenat, et al.Plant Molecular Biology|February 20, 2010
Negative regulation of the RTBV promoter by designed zinc finger proteinsM Isabel Ordiz, Laurent Magnenat, Carlos F Barbas, et al.Mabs|November 18, 2016
Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®Laurent Magnenat, Angelo Palmese, Christèle Fremaux, et al.Nature Immunology|April 26, 2011
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammationLaura Codarri, Gabor Gyülvészi, Vinko Tosevski, et al.Protein Expression and Purification|September 21, 2010
A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditionsVincent Dechavanne, Nicolas Barrillat, Frederic Borlat, et al.Biochemistry|February 20, 2003
Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteinsDavid J Segal, Roger R Beerli, Pilar Blancafort, et al.Journal of Pharmaceutical Sciences|December 16, 2023
An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of BiopharmaceuticalsJohn M Campbell, Stefano Colombo, Jamie L Doyle, et al.Pageof 1